Download presentation
Presentation is loading. Please wait.
Published byΜελέαγρος Μιαούλης Modified over 6 years ago
1
Gynecologic and hormonal effects of raloxifene in premenopausal women
Ahalya Premkumar, M.D., David J. Venzon, Ph.D., Nilo Avila, M.D., Diane V. Johnson, R.T., R.D.M.S., Alan T. Remaley, M.D., Ph.D., Michele R. Forman, Ph.D., M.S., Jennifer Eng-Wong, M.D., M.P.H., JoAnne Zujewski, M.D., Pamela Stratton, M.D. Fertility and Sterility Volume 88, Issue 6, Pages (December 2007) DOI: /j.fertnstert Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions
2
Figure 1 Ovarian stimulation. (A) Transvaginal sonogram with color Doppler shows bilateral corpora lutea. (B) Large bilateral ovarian cysts seen in a subject on raloxifene. Fertility and Sterility , DOI: ( /j.fertnstert ) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions
3
Figure 2 Uterine polyps. Saline infusion sonohysterogram at 12 months after raloxifene shows multiple endometrial polyps (arrows). Fertility and Sterility , DOI: ( /j.fertnstert ) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.